Home » Health »
Latest News »
New York Times »
NYT
» Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.
Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.
By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3tZVqr6
via IFTTT
0 Response to "Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year."
Post a Comment